Transcatheter mitral valve repair and replacement is a minimal-invasive technique for the treatment of asymptomatic chronic moderate to severe or severe mitral regurgitation (MR). Mitral valve is positioned between two left chambers of the heart. It aids by keeping the blood flow properly in one direction from the left atrium to the left ventricle and avoids it from flowing backward. Mitral valve replacement is performed when the valve becomes too tight for the blood to flow into the left ventricle.
Growth in the geriatric population and rise in mitral valve disorders drive market growth.
In addition, technological advancements coupled with the introduction novel mitral valves are the other factors that drive the market growth. The major restraint observed for this market is the strict regulations by the governing bodies as well as the high cost of mitral valve surgeries and high risk associated with these procedures. Moreover, the rise in healthcare expenditure and emergence in developing countries will create lucrative opportunities for key market players. The transcatheter mitral valve repair & replacement market was valued at $324 million (excluding the revenue from replacement valves) in 2016 and is expected to reach at $1,878 million (both repair and replacement valves) by 2023, registering a CAGR of 30.0% from 2017 to 2023.
The transcatheter mitral valve replacement (TMVR) market is segmented based on the product, indication, and region. Based on the product, the market is bifurcated into mechanical valves and bioprosthetic tissue (biological) valves. Based on indication, the market is classified into mitral valve stenosis, mitral valve prolapse, and mitral valve regurgitation. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the global transcatheter mitral valve repair & replacement market, with current trends and future estimations to elucidate the imminent investment pockets.
Comprehensive analysis of factors that drive and restrict market growth is provided.
Comprehensive quantitative analysis of the industry from 2016 to 2023 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of the key segments of the industry helps understand the type of products and technologies used globally.
Key market players and their strategies are provided to understand the competitive outlook of the market.
KEY MARKET SEGMENTS
Bioprosthetic Tissue (Biological) Valves
Mitral Valve Stenosis
Mitral Valve Prolapse
Mitral Valve Regurgitation
Rest of Europe
Rest of Asia-Pacific
Rest of LAMEA
KEY PLAYERS PROFILED
Biotronik Pvt Ltd
Colibri Heart Valve, LLC
Coramaze Technologies GmbH
The other players in the value chain include (profiles not included in the report)
Transcatheter Technologies GmbH
Note: The study forecast period can be customize as per the request
Get more information, Ask for free sample copy: https://www.reportocean.com/industry-verticals/sample-request?report_id=27159
We are the best market research reports provider in the industry. Report Ocean believe in providing the quality reports to clients to meet the top line and bottom-line goals which will boost your market share in today’s competitive environment. Report Ocean is ‘one-stop solution’ for individuals, organizations, and industries that are looking for innovative market research reports. We will help you in finding the upcoming trends that will entitle you as a leader in the industry. We are here to work with you on your objective which will create an immense opportunity for your organization.
Company Name: Report Ocean
Address: Classic Tower, Rajnagar Extension, Ghaziabad, 201017 – India
Contact: +1 888 212 3539 (US) +91-9997112116 (Outside US)
Contact Person: Sandeep Singh
Email: [email protected]